1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde

Catalog No. :
ACHMLA418
CAS No. :
4869-46-9
Molecular Formula :
C7H8N2O3
Molecular Weight :
168.15

IUPAC Name:1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde

1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g96%$55.00Login to see priceIn stockInquiry
5g96%$218.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde
IUPAC Name1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde
MDL No.MFCD00099582
Molecular FormulaC7H8N2O3
Molecular Weight168.15
SMILESO=CC1=CN(C)C(N(C)C1=O)=O
InChI KeyKGJFRZOATIXYPW-UHFFFAOYSA-N
Synonym1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde | AKOS000267626 | AMY1927 | CS-0128414 | EN300-25487 | 1,3-dimethyl-2,4-dioxopyrimidine-5-carbaldehyde | 1,3-Dimethyluracil-5-carboxaldehyde | SCHEMBL3078617 | SY109393 | SB57754 | Z208293
CAS No.4869-46-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACHMLA418 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHMLA418 route product structure diagram
    ACHMLA4184869-46-9 In Stock
Inquiry

2. ACHMLA418 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTDRK548 route compound structure diagram
    ACTDRK5481195-08-0 In Stock
  4. Then
  5. ACHMLA418 route product structure diagram
    ACHMLA4184869-46-9 In Stock
Inquiry

Comments (0)